VA Launches $1 Million Tech Sprint to Address Healthcare Worker Burnout
The U.S. Department of Veterans Affairs (VA) is taking action to tackle healthcare worker burnout by launching a “tech sprint” focused on developing artificial intelligence (AI) tools. The VA is offering a combined $1 million in prizes to companies that can create automated note-taking tools for doctors and software that can integrate medical records from different sources. The goal is to reduce administrative burden and allow healthcare professionals to spend more time with patients. The initiative comes in response to President Joe Biden’s executive order on AI, which aims to safeguard national security and society while promoting responsible AI development.
Masimo Uses Import Ban on Apple Watches as Leverage in Patent Battle
Medtech company Masimo hopes that a recent ruling by the International Trade Commission (ITC) to ban the importation of certain Apple Watches could help them reach a settlement in their ongoing patent dispute with Apple. Masimo CEO Joe Kiani claims that his company has spent over $65 million on litigation related to its patented blood oxygen sensor technology used in smartwatches and fitness trackers. The ITC ruling could be a significant bargaining chip for Masimo as it seeks to resolve the long-standing dispute with the tech giant.
FDA Approvals: New Drugs and Treatments Gain Regulatory Clearance
The U.S. Food and Drug Administration (FDA) has been active in granting approvals for new drugs and treatments. This includes Lilly’s first-in-class ulcerative colitis drug, Omvoh, Novartis’ Cosentyx for hidradenitis suppurativa, Genetech’s eye treatment Vabysmo, and Coherus and Junshi Biosciences’ Loqtorzi for nasopharyngeal carcinoma. Additionally, Santhera Pharmaceuticals received approval for its drug Agamree to treat Duchenne Muscular Dystrophy. However, Roche and Sarepta Therapeutics faced setbacks as their phase III trial for a DMD drug failed to meet its primary endpoint but did meet several secondary endpoints.
Innovation and Investments in Healthcare
Various companies have made significant strides in healthcare innovation and secured funding for their projects. Imagine Pharma raised $32.5 million for its polypeptide drug candidate, which could have broad therapeutic applications. Gate Bioscience emerged from stealth mode with a $60 million series A funding round to advance its development of small molecules targeting extracellular proteins. AstraZeneca also entered into a collaboration with Cellecitis to develop new gene and cell therapies, signaling further expansion of gene therapy advancements. Overall, these investments showcase the ongoing progress and potential within the healthcare industry.
Abridge Raises $30 Million to Compete with Microsoft’s AI Notetaker
Healthcare startup Abridge has raised $30 million in a series B funding round led by Spark Capital. The company offers AI-based medical note-taking technology that is used by thousands of doctors. Abridge competes with Nuance, a company acquired by Microsoft for $18.8 billion, which also provides dictation software for medical professionals. The race to dominate the market for AI medical scribes remains open, with advancements in automated note-taking technology driving competition and innovation.
Other Healthcare News: CVS, GlaxoSmithKline, RSV Vaccine, and More
In other news, CVS Health reported net income of $2.2 billion, bolstered by its acquisitions of Oak Street Health and Signify Health. GlaxoSmithKline increased its profit forecast due to high demand for its new RSV vaccine. Sanofi and AstraZeneca are facing limited supply of their RSV immunization for infants, prompting the CDC to recommend prioritizing doses for high-risk infants. A report found that over one in five coronary stents in the U.S. were unnecessary, costing Medicare $800 million annually and putting patients at risk. The European Union agency concluded that weight loss drugs, such as Ozempic and Wegovy, do not have a proven link to thyroid cancer. Lastly, a patient who received the second-ever pig heart transplant died six weeks after the surgery, highlighting both the challenges and potential of this innovative medical procedure.
What are your thoughts on these recent developments in healthcare? Have you experienced or witnessed clinician burnout firsthand? Share your opinions and experiences in the comments section below.
IntelliPrompt curated this article: Read the full story at the original source by clicking here